''We'd definitely be in a much better position if they had have successfully sold the story and cap raised at a much higher price. ''
Precisely....this is exactly my point....In my post, I said if they had done this the sp would have taken care of itself
Just about every single biotech on the ASX has manged to do this, except DXB
So how do you and I differ then?
''We'd definitely be in a much better position if they had have...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 394907 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 15948 | 1 |
View Market Depth
| Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |